Cardio Diagnostics Holdings, Inc. (CDIO)
NASDAQ: CDIO · Real-Time Price · USD
1.720
-0.100 (-5.49%)
At close: Apr 28, 2026, 4:00 PM EDT
1.730
+0.010 (0.58%)
After-hours: Apr 28, 2026, 6:44 PM EDT
CDIO Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 0.01 | 0.03 | 0.02 | 0 | 0 | |
| Revenue Growth (YoY) | -57.51% | 104.45% | 1696.32% | 5.44% | - | |
| Gross Profit | 0.01 | 0.03 | 0.02 | 0 | 0 | |
| Selling, General & Admin | 5.79 | 8.15 | 7.1 | 4.49 | 0.57 | |
| Research & Development | 0.64 | 0.23 | 0.15 | 0.04 | 0.03 | |
| Amortization of Goodwill & Intangibles | 0.07 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Operating Expenses | 6.5 | 8.4 | 7.26 | 4.55 | 0.62 | |
| Operating Income | -6.48 | -8.37 | -7.24 | -4.55 | -0.62 | |
| Interest Expense | -0.01 | -0.02 | -6.74 | - | - | |
| Interest & Investment Income | 0 | 0 | 0 | - | - | |
| Other Non Operating Income (Expenses) | - | - | 5.41 | - | - | |
| EBT Excluding Unusual Items | -6.5 | -8.38 | -8.57 | -4.55 | -0.62 | |
| Merger & Restructuring Charges | - | - | - | -0.11 | - | |
| Other Unusual Items | - | - | 0.19 | - | - | |
| Pretax Income | -6.5 | -8.38 | -8.38 | -4.66 | -0.62 | |
| Net Income | -6.5 | -8.38 | -8.38 | -4.66 | -0.62 | |
| Net Income to Common | -6.5 | -8.38 | -8.38 | -4.66 | -0.62 | |
| Shares Outstanding (Basic) | 2 | 1 | 0 | 0 | 0 | |
| Shares Outstanding (Diluted) | 2 | 1 | 0 | 0 | 0 | |
| Shares Change (YoY) | 95.38% | 112.00% | 310.83% | 165.44% | 12.35% | |
| EPS (Basic) | -3.71 | -9.35 | -19.81 | -45.29 | -16.00 | |
| EPS (Diluted) | -3.71 | -9.35 | -19.81 | -45.29 | -16.00 | |
| Free Cash Flow | -5.91 | -5.21 | -6.25 | -5.09 | -0.59 | |
| Free Cash Flow Per Share | -3.38 | -5.81 | -14.78 | -49.46 | -15.10 | |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | |
| Operating Margin | -43737.46% | -23977.87% | -42440.43% | -478784.32% | -68862.15% | |
| Profit Margin | -43832.49% | -24028.24% | -49087.81% | -490630.00% | -68862.15% | |
| Free Cash Flow Margin | -39893.09% | -14926.54% | -36612.00% | -535891.37% | -64960.15% | |
| EBITDA | -6.09 | -8.09 | -7.13 | -4.53 | -0.6 | |
| D&A For EBITDA | 0.4 | 0.28 | 0.11 | 0.02 | 0.02 | |
| EBIT | -6.48 | -8.37 | -7.24 | -4.55 | -0.62 | |
| Advertising Expenses | 0.11 | 0.18 | 0.16 | 0.09 | 0.1 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.